Thyroid hormones (TH) are essential for brain development. However, information on if and how this key endocrine factor affects adult neurogenesis is fragmentary. We thus investigated the effects of TH on proliferation and apoptosis of stem cells in the subventricular zone (SVZ), as well as on migration of transgene-tagged neuroblasts out of the stem cell niche. Hypothyroidism significantly reduced all three of these processes, inhibiting generation of new cells. To determine the mechanisms relaying TH action in the SVZ, we analyzed which receptor was implicated and whether the effects were played out directly at the level of the stem cell population. The α TH receptor (TRα), but not TRβ, was found to be expressed in nestin positive progenitor cells of the SVZ. Further, use of TRα mutant mice showed TRα to be required to maintain full proliferative activity. Finally, a direct TH transcriptional effect, not mediated through other cell populations, was revealed by targeted gene transfer to stem cells in vivo. Indeed, TH directly modulated transcription from the c-myc promoter reporter construct containing a functional TH response element containing TRE but not from a mutated TRE sequence. We conclude that liganded-TRα is critical for neurogenesis in the adult mammalian brain.
olfactory lobe (3) . Some cells may also generate glial cells in the corpus callosum (4) . To exploit the therapeutic potential of endogenous stem cells, knowledge of the intrinsic and extrinsic mechanisms affecting NSC population size and expansion is needed. However, few studies have addressed endocrine control of NSC function, particularly in vivo (5) .
The thyroid hormones (TH) are essential for brain development in all vertebrates (6) . The main secreted form of TH is thyroxine (T 4 ), which is converted to the biologically more active form triiodothyronine (T 3 ), in peripheral tissues. In each species studied, TH levels are highest during the period of most rapid brain growth and development, which in humans occurs during the first 2 yr of postnatal life. Lack of TH in early development causes severe neurological damage and results in cretinism in man (7) . At the cellular level, TH action on specific cells and at specific phases of development is known to be a major factor in regulating the timing of proliferation and differentiation decisions in a number of neural and nonneural cellular populations including retinal progenitors (8) (9) (10) , oligodendrocyte precursors (11, 12) , and erythroid precursors (13) . Thus, although it is known that transient exposure of NSCs to TH in vitro initiates a stable switch to a glial fate through a direct, instructive mechanism (14) , the potential effects of TH on NSC proliferation and survival have yet to be characterized in their in vivo context.
MATERIALS AND METHODS

Treatment of animals, in vivo transfection, and luciferase assay
All animal studies were conducted according to the principles and procedures described in Guidelines for Care and Use of Experimental Animals.
To induce hypothyroidism or hyperthyroidism, female OF1 mice (Janvier, Le Genest St. Isle, France) were given, respectively, an iodine deficient food containing 0.15% 6-n-propyl-2-thiouracil (PTU from Harlan Teklad, Madison, WI) or a solution of T 3 1.5 µM (Sigma, SaintQuentin Fallavier, France) diluted in the drinking water both for 2 wk. To confirm their thyroid status, T 3 levels in plasma were determined using Amerlex-T 3 RIA-kit (Trinity Biotech, Wicklow, Ireland). T 3 values in PTU-treated, control, and hyperthyroid animals were 19.6 ± 1.9, 49.4 ± 2.5, and 415.5 ± 35 ng/dl, respectively (means±SE, n= 6 for each group). For evaluating T 3 effects on reporter gene expression, animals were injected intraperitonealy with 10 µg of T 3 /30 g body wt (in 9‰ saline). Controls received saline (9‰) injections. Luciferase activity was measured in tissue homogenates as described previously (15) .
Animals
TRβ
−/− mice (16), lacking TRβ1 and TRβ2, and TRα 0/0 mice (17), lacking TRα1, TRa2, TR∆α1, and TR∆α2, were maintained on a 129/Sv strain. The DNA construct for gene targeting was engineered to associate the disruption of the TR gene with an in-frame insertion of the lac-Z reporter gene. Wild-type 129/Sv mice were purchased from Charles River Laboratories (L'Arbresle, France).
Plasmid preparation, formulation of polyethylenimine/DNA complexes, and stereotaxic injection
The c-myc promoter fragment (murine origin [-1141/+516] a generous gift from Dr. Garcia-Silva from the laboratory of Dr. Aranda, Instituto de Investigaciones Biomedicas "Alberto Sols," Universidad Autonoma of Madrid, Spain) was inserted in pGl2 basic vector from Promega (Madison, WI) upstream of the coding sequence of firefly (Photinus pyralis) luciferase. The same promoter fragment was mutated in the TRE using the QuickChange XL site-directed mutagenesis kit from (Stratagene) and the primer 5′-GGGGCGACCTAAGACTGCAGCAATGGAGTGAGAGGGGC-3′.
Endotoxin-free DNA was prepared using affinity columns (Genomed, Research Triangle Park, NC). Plasmid DNA (1 µg per animal) was diluted in 5% glucose to the chosen concentration, complexed with 22 kDa linear polyethylenimine (PEI; ratio of 6 PEI nitrogens per DNA phosphate, ref 18) , and then vortexed. One single injection (5 µl) was performed into either right or left lateral ventricle (0.2 mm posterior to bregma line, 1.1 mm lateral, and 2.2 mm deep from the pial surface) of 2-mo-old OF-1 mice (Janvier) anaesthetized with 60 mg/kg pentobarbital (Sanofi, Paris, France). As previously shown (19) , this mode of nonviral plasmid delivery results in preferential transfection of adult NSCs and their immediate progeny in the SVZ. Therefore, it provides an ideal system to monitor effects of TH on gene expression after PEI-mediated transfection.
To follow migration in the rostral migratory stream (RMS), we performed intraventricular injections of PEI complexed plasmid pCMV-LacZ to genetically label NSCs and their progeny (19) . One week after injections, saggital vibratome sections (80 µm) were prepared and stained for β-galactosidase (19) . Transgene expressing cells that had migrated from at least 100 µm from the ventricle were counted.
Histological techniques
Mice were deeply anesthetized with 130 mg/kg pentobarbital (Sanofi) and then sequentially perfused (3 ml/min) with saline solution (0.9‰ NaCl) and 2% paraformaldehyde (PFA). Brains were dissected and postfixed in 2% PFA. Immunohistological reactions were performed on cryostat sections (10 µm).
Bromodeoxyuridine (BrdU; Fluka, Saint-Quentin Fallavier, France) was administered in the drinking water (1 mg/ml) for 2 wk or by intraperitoneal injection (150 mg/kg) 3 days or 2 h before death.
The 2 wk administration allows labeling of the relatively quiescent population including the slow-dividing stem cells. The 3 days pulse of BrdU labels more rapidly proliferating cells. In normal conditions, the 3 days chase allows these cells to dilute BrdU, whereas the relatively quiescent cells retain the BrdU label (20) (21) (22) . Two hours of BrdU treatment labels actively cycling cells.
BrdU labeling was done using a monoclonal mouse anti-BrdU antibody (Dako, Trappes, France) at a 1:50 dilution in PBS containing 1% bovine serum albumin (BSA). Antigenic sites were unmasked by two microwave cycles (5 min at 750 W, in 10 mM citrate buffer, pH 6). To minimize endogenous reactivity with monoclonal antibody, we made use of the Dako ARK peroxidase conjugated revelation system (Dako, Trappes, France).
Polyclonal rabbit antibody anti-phosphorylated histone H3 (Upstate, Lake Placid, NY) was applied at a 1:200 dilution. Polyclonal rabbit antibody anti-Ki67 (Novocastra Laboratories, Newcastle upon Tyne, UK) was applied at a 1:1000 dilution. Polyclonal rabbit antibody antiactivated caspase-3 (BD PharMingen, Franklin Lakes, NJ) was applied at a 1:200 dilution.
For TH receptor detection, we used polyclonal antibodies directed against the TRα1 isoform (1:10, overnight, 4°C) and TRβ isoform (see ref 23 , 1:50 overnight 4°C) on cryostat sections (10 µm). The TRα1 antibody was raised against a C-terminal peptide and affinity-purified with the same peptide (a gift from Dr. Plateroti, Ecole Normale Supérieure Lyon). Antigenic sites were previously unmasked by two microwave cycles (5 min at 750 W, in 10 mM citrate buffer, pH 6).
The primary monoclonal antibody anti-nestin (BD PharMingen) was applied at 1:500 dilution. Triple labeling with either TRα or TRβ (green) on DAPI (1 µg/ml) stained sections (blue nuclei) was performed revealing anti-nestin with secondary anti-mouse IgG1 antibody conjugated with Cy3 (red) from Sigma. Nestin labeling on β-galactosidase stained cryostat sections (10 µm) of TR null mice was revealed using Dako ARK (Dako).
We used secondary antibody biotinylated anti-rabbit (1:800, 1 h, room temperature) that was revealed using extravidin-Cy3 (1:5000, 1 h, room temperature), both from Sigma. We used secondary antibody anti-rabbit peroxidase conjugated at 1:200, 1 h, room temperature (Dako).
Semithin sections of TR null mice were prepared from vibratome sections previously stained with a 2 mM BluoGal (Life Technologies, Cergy Pontoise, France) solution as described previously (24) .
Statistical analysis of results
Each set of cell counts (BrdU, PhosH3, Ki67, and caspase-3 positive cells) were performed on sections taken from 0.7 to 1.2 mm anterior to bregma and carried out double-blindly by two observers.
In vivo gene transfer and cell counts results are means ± SE per group. After ANOVA analysis where appropriate, Kruskal-Wallis test was used to analyze differences between groups. Differences were considered significant at P < 0.05. In all cases, typical experiments are shown. Each experiment was carried out with n ≥ 6, repeated at least three times, and provided the same results.
RESULTS
Hypothyroidism reduces NSC proliferation
We modified the thyroid status of adult mice and examined DNA synthesis and proliferation in the SVZ. We used two distinct protocols to label differentially BrdU-incorportating cells. First, to label dividing neural progenitors, BrdU was given punctually for 3 days before death. An alternative protocol in which 2 wk BrdU exposure was followed by a 3 day BrdU-free chase period was used so as to label slowly proliferating cells. In this protocol, the chase period will result in loss, by dilution, of the BrdU signal from the rapidly dividing progenitor population but not from the slow-dividing cells or cells that have exited the cell cycle. Induction of hypothyroidism by propylthiouracil (PTU) treatment (see Materials and Methods) increased numbers of cells in the SVZ-incorporating BrdU in both protocols ( Fig. 1A and B) . Close examination of the labeled cells revealed that hypothyroidism actually resulted in increased intensity of the BrdU signal (Fig. 1A , lower panels) in individual cells. This observation suggests that once acquired, the BrdU labeling is not diluted by successive cell divisions, indicating that cells are either not completing the cell cycle and/or not undergoing further divisions. We therefore chose to examine the actual mitotic state of the cells.
To quantify proliferation, we used the active cell cycle marker Ki67 that labels cells in G 1 , S, G 2 , and M phases (25) and phosphorylated histone H3 (PhosH3) (26) (27) (28) . PhosH3 increases in G 2 and is maximal in M phase and is rapidly lost as cells enter G 1 (27, 29) . Hypothyroidism significantly reduced PhosH3-positive cells in the SVZ ( Fig. 2A-C, P<0 .001) and halved the number of Ki67 positive cells in the SVZ (Fig. 2D ). These apparently contradictory results from BrdU and cell cycle markers studies are reconcilable if, in hypothyroidism, cells accumulate BrdU but do not re-enter the cell cycle.
Taken with the data on proliferation, we infer that the increased BrdU labeling seen in hypothyroid animals is indicative of increased number of cells that have synthesized DNA but have exited the cell cycle. Thus, we further characterized the cell cycling state of resting progenitors in the SVZ. We performed double labeling between Ki67 (actively cycling cells) and BrdU incorporation after a 3 day BrdU treatment (Fig. 2E) . The proportion of cells that have synthesized DNA but do not re-enter the cell cycle increases in hypothyroid mice, indicating that absence of TH results in accumulation of resting progenitors in the SVZ (Fig. 2F) .
Hypothyroidism limits NSC migration
To test whether TH affects the migratory capacity of NSC progeny, we used an in vivo gene transfer protocol that specifically labels NSC by expression of an exogenous reporter gene. This technique exploits PEI, which specifically targets plasmid DNA to the SVZ stem cell and neuroprogenitor population in vivo (19) . Stereotaxic delivery of PEI-condensed DNA encoding lac-Z to the SVZ resulted in β-galactosidase expression in cells in the SVZ and in the RMS (Fig.  3A and B) . Hypothyroidism halved (P<0.05) the numbers of lac-Z expressing cells in the RMS (Fig. 3B) .
Apoptosis is the fate of most progenitors arising from NSC division in the SVZ (2). To investigate whether thyroid status modifies apoptosis in the SVZ, we followed activated caspase-3, one of the ultimate players in the apoptosis program (ref 30 and Fig. 3D and E) . Hypothyroidism halved (P<0.05) the number of caspase-3 positive cells in this region (Fig. 3E) . Reduction of apoptosis could also contribute to increased numbers of BrdU-labeled cells accumulating in the SVZ during hypothyroidism.
TH regulates NSC proliferation through the TRα receptor
The data so far indicate that TH is required for NSC to pass through mitosis and enter the differentiation or apoptosis programs. The question then arises of the mechanisms underlying these actions and whether they are direct. TH regulates gene transcription through TH receptors that are transcription factors belonging to the steroid hormone/retinoic acid receptor superfamily (31) . In vertebrates, two genes encode TH receptors, TRα and TRβ (32) . Immunocytochemistry with TH receptor specific antibodies (see Materials and Methods) showed TRα1, but not TRβ, to be expressed in the nestin-expressing cells of the SVZ (Fig. 4A and B) . TRα 0/0 mice and TRβ
mice lack all isoforms produced from the TRα or the TRβ loci, respectively (33) . To examine further TR expression in the SVZ, we used β-galactosidase as a marker for TR-expressing cells in TR mutant mice ( Fig. 4C and D) and homozygous null mice ( Fig. 4E and F) . β-galactosidase staining reflecting expression from the TRα promoter was strong in the SVZ of TRα mutant mice (Fig. 4C, E, and G) . In contrast, in TRβ mutant mice no β-galactosidase staining could be detected suggesting low or undetectable levels of TRβ expression in this area (Fig. 4D, F , and H). β-Galactosidase staining was carried out together with nestin immunochemistry to label the SVZ NSCs and progenitor cells in homozygous animals. Noticeably, nestin expression in the TRα 0/0 mice was markedly reduced (compare Fig. 4I and J) differing from the usual pattern recapitulated in TRβ −/− mice, where nestin-positive extensions reach out perpendicularly from the SVZ toward the striatum.
Given the specific expression of TRα in the SVZ, we followed DNA synthesis and mitosis in TRα 0/0 mice, maintained under euthyroid conditions. BrdU accumulation after a 3 day treatment was significantly increased in TRα 0/0 mice compared with wild-type counterparts (Fig. 4K-M) . Inversely, PhosH3-positive cells were halved in TRα 0/0 mice (Fig. 4N) . Thus, TRα absence inhibits progression of NSC through the cell cycle and suggests a role for TRα in mediating TH effects on NSC cycling.
TH directly regulates gene expression and proliferation in the NSC population
Expression of the TRα gene in the SVZ strongly argues for a direct effect of TH on transcriptional regulation in these stem cells. To assess whether this is the case, we used PEImediated gene delivery to introduce into the stem cells a construction containing 1.6 kb of the mouse c-myc promoter cloned upstream of the luciferase gene. Hypothyroidism doubled transcription from the c-myc promoter, whereas transcription was repressed in animals treated with T 3 for 2 wk with expression levels not different from controls (Fig. 5A) . In a second protocol, hypothyroid mice were transfected with c-myc-luc and immediately exposed to T 3 for 3 days. Again, in this short T 3 exposure experimental paradigm T 3 significantly reduced transcription from the c-myc promoter in vivo (Fig. 5B) . Thus, both long-term (2 wk) and shortterm (36 h) T 3 treatment reduce transcription from the c-myc promoter in adult SVZ NSCs and their progeny. This TH effect was direct as it was lost if the TRE in the c-myc promoter was mutated (Fig. 5B) .
The above findings suggest a direct action of TH on stem cell activity and should implicate a rapid response to TH. To estimate the delay of action of TH on proliferation, we went back to a BrdU incorporation protocol. However, this time the protocol differed from those used in the initial experiments in that it was a short, 2 h pulse of BrdU as opposed to a long treatment (2 wk) followed or not by a chase. We applied this 2 h BrdU incorporation protocol on hypothyroid mice that were injected either with T 3 solution for 10 h before death (i.e., 8 h before BrdU treatment) or with saline control solution ( Fig. 5C and D) . With this short pulse of BrdU that only labels cells in S phase, we observed significantly more positive cells in euthyroid mice than in hypothyroid mice (Fig. 5E) . The rapid treatment with T 3 fully restored the number of cells in S phase to the euthyroid levels (Fig. 5E) , again arguing for a direct effect of TH on proliferation.
DISCUSSION
Thyroid hormone has long been known to regulate neurodevelopment in all vertebrates. In humans, if hypothyroidism occurs early in development (in the fetus or neonate), it causes mental retardation and profound deafness. Much work on the complex roles of TH in neurodevelopment has shown that TH must act within a critical window of developmental time, beyond which hormone replacement cannot recover normal function. Moreover, TH actions are widespread, affecting many structures both during early development and later as a maturation factor (34) .
Given these key actions of TH during brain development, we chose to analyze whether thyroid status affected adult neurogenesis. A first result was that lack of TH severely hampers the proliferative potential of the stem cell population in the SVZ of the adult mouse brain. We used a number of different protocols to follow the kinetics of DNA synthesis (BrdU accumulation) and to quantify the number of cells actually undergoing mitosis at any given time in different thyroid states. We show that lack of TH reduces mitotic figures in the SVZ and that a short pulse of TH revives the process. This rapid effect of TH on mitotic activity within hours in the SVZ suggests that TH is acting directly on the stem cell population.
A second set of data arguing for a direct effect of TH includes the demonstration of TRα expression in the SVZ. These observations exploited deconvolution confocal microscopy on wild-type animals and LacZ expression in animals in which this gene had been used as an inframe insertion to disrupt the expression of the endogenous TR gene. Further, use of mutant mice lacking the TRα receptor showed that absence of this receptor reproduces the effect of hypothyroidism on mitotic capacity of SVZ NSCs. Two genes encode the related TRα and TRβ receptors across all vertebrate species, suggesting that both genes are essential for TH action. Alternative splicing and differential use of promoters produces a variety of isoforms from each TR gene, including TRα1, TRα2, TRβ1, and TRβ2. In TRα 0/0 mutant mice not only TRα1 is absent but also TRα2 and some truncated C-terminal products. However, TRα2 and the truncated forms are unable to bind TH and, therefore, TRα1 is the only bona fide TH receptor that can mediate T 3 neurogenic action in the SVZ. TRα1 presence in the SVZ is revealed by immunodetection with the specific anti-TRα1 antibody. In early neurodevelopment, TRα1 is widely expressed, whereas TRβ variants are more restricted (34) . The role of TRα receptor in neurogenesis is underscored by our findings that TRα continues to be expressed in one of the few parts of the CNS that maintains a proliferative potential in the adult and that lack of the gene products hampers proliferation to the same extent as lack of TH. The data also corroborate previous results showing a role for TRα in regulating mitosis in chick embryo neuroblasts (35) and the finding that an EST similar to TRα was found in a genomic expression profile of NSC (36) . Another intriguing finding in the TRα 0/0 mice is the disruption of nestin expression patterns, also observed by Morte et al. (37) using another line of mutant mice lacking specifically TRα1. Furthermore, apoptosis, known to be the major fate of NSCs progeny in the SVZ and which is probably closely linked to cell cycle to balance proliferation (22) , is also affected by hypothyroidism. Taken together, these results indicate that not only proliferation but the entire organization of the stem cell niche is affected by lack of TH.
A third line of argument for a direct role of TH on NSC biology comes from the finding that TH regulates transcription from a promoter sequence delivered into this population. In these in vivo gene transfer experiments, we exploited an approach that had previously been proven to target gene transfer to the stem cell population (19) in which we used electron-microscopy to reveal triple colocalization of exogenous reporter gene products with mitotic and stem cell markers, specifically within stem cells in the adult SVZ. This targeted gene transfer technique thus privileges delivery of exogenous genes specifically to the stem cell population. This targeting is probably due to their proliferative capacity (38) and/or the expression in the stem cells niche of proteoglycans that have been identified as receptors for cationic polyplex delivery (39) and that are present on neural precursor cells (40) . Using this technique, we find that injecting T 3 into hypothyroid mice represses transcription from a c-myc promoter-driven luciferase construct introduced into the stem cell population. This transcriptional effect must be direct, as it is lost when the TH response element in the promoter is mutated. The data are consistent with results showing that TH-induced differentiation of neuroblastoma cells is preceded by a rapid decrease of c-myc gene expression through a negative T 3 responsive element in the promoter (41) . Further, the finding that transcription from the c-myc promoter is up-regulated in NSC of hypothyroid mice could indicate that endogenous c-myc is regulated by TH the NSC. Indeed, given the fact that c-myc is known to be a T 3 dependent gene and that c-myc regulation is related to cell cycle control, it is tempting to speculate that endogenous c-myc may be a key target gene relaying the effects of T 3 on neural progenitors cycle.
These in vivo findings show that TH intervenes in the earliest stages of stem cell biology, i.e., in the decision to initiate and undergo proliferation. In the SVZ, TH deficiency results in abnormal accumulation of BrdU positive cells, indicative of failure to re-enter the cell cycle on the one hand and of reduced apoptosis on the other. Similarly, the absence of TRα, normally expressed in the SVZ, also blocked cell cycle progression. These data suggest that, besides the wellestablished multiple roles of TH in early neurogenesis, TH is an essential component of the endocrine environment that activates NSC growth, migration, and apoptosis. Further, the results demonstrate that the negative effects of TH on mitotic capacity have repercussions on the number of cells migrating through the RMS. Recent work identifies NSCs in the adult human brain, which remain relatively quiescent in vivo (42) , suggesting the importance of the cellular environment to activate stem cells. Endocrine factors such as TH could be key factors to reveal regenerative potential of endogenous or grafted stem cells.
Taken together these findings could have far-reaching clinical implications particularly in an aging population that is prone to hypothyroidism. Indeed, hypothyroidism is associated with loss of sense of smell in rodents (43) and more importantly, in humans with cognitive decline and depression (44, 45) . Furthermore, as active neurogenesis is required to see the behavioral effects of anti-depressants (46) , it is tempting to speculate that the link between hypothyroidism and depression could implicate reduced neurogenesis. complexed with PEI was transfected into the NSC population and progenitors of the SVZ by intraventricular injection. Animals were treated with PTU for 2 wk prior to transfection and with T 3 for either 3 days (A) or 36 h (B) before death. After PTU treatment, luciferase expression was significantly higher (***P<0.001) than that observed in T 3 treated or control animals. No effect of T 3 was seen on the c-myc promoter in which the TRE had been mutated (B, right pair of columns). Means ± SE are given; n = 6 animals per group. C-E) BrdU incorporation after a 2 h pulse of BrdU in hypothyroid (C) or hypothyroid animals treated with T 3 for 10 h (D). Note that a 10 h T 3 treatment restores the number of cells synthesizing DNA to levels of control, nontreated animals (E).
